FindTrial
Sign In

COMPARISON OF INJECTION CARBETOCIN WITH INJECTION OXYTOCIN IN VAGINAL DELIVERY FOR PREVENTION OF BLOOD LOSS

INJECTION CARBETOCIN VERSUS INJECTION OXYTOCIN IN VAGINAL DELIVERY FOR PREVENTION OF POST-PARTUM HEMORRHAGE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/063466
Enrollment
200
Registered
2024-03-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O721- Other immediate postpartum hemorrhage

Interventions

None listed

Sponsors

DATTA MEGHE INSTITUTE OF HIGHER EDUCATION AND RESEARCH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: REPRODUCTIVE AGE GROUP AND ELIGIBLE FOR STUDY SINGLETON PREGNANCY TERM GESTATION

Exclusion criteria

Exclusion criteria: WOMEN WITH KNOWN COAGULOPATHY STUDY DRUG HYPERSENSITIVITY OLIGOHYDRAMNIOS OR POLYHYDRAMNIOS CARDIAC DISEASES (INCLUDING DYSRHYTHMIA) HYPERTENSION LIVER,RENAL OR ENDOCRINE DISEASES (EXCEPT GESTATIONAL DIABETES) UTERINE FIBROIDS OR SUSPICION OF PLACENTAL PATHOLOGY (ACRETA, PREVIA OR ABRUPTIO)

Design outcomes

Primary

MeasureTime frame
INTRA-PARTUM BLOOD LOSS UTERINE TONETimepoint: 24 HOURS—

Secondary

MeasureTime frame
DIFFERENCE IN HEMOGLOBIN TAKEN BEFORE THE VAGINAL DELIVERY AND 48 HOURS AFTER VAGINAL DELIVERY NEED FOR ADDITIONAL UTEROTONICS EVALUATION OF NAUSEA AND VOMITINGTimepoint: 48 HOURS—

Countries

India

Contacts

Public ContactPALLAVI

JAWAHARLAL NEHRU MEDICAL COLLEGE, WARDHA, MAHARASHTRA

DRARPITAJAISWAL@GMAIL.COM

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026